Replies to post #19075 on Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

Yes. DR-70/ CIT seems to weave its way into a lot of various research. We need the patent sresolved, and look for the news to appear. Regardless of what some people will say, RXPC has retained ownership of both and will be the primary beneficiary of same.